HealthEquity Trading Volume Surges to 470th Position Despite Slight Stock Decline

On March 25, 2025, HealthEquity (HQY) experienced a significant trading volume of $187 million, marking a 35.64% increase from the previous day. This surge placed the company's trading volume at the 470th position in the overall market. However, despite the high trading volume, the stock price of HealthEquity (HQY) closed the day with a slight decrease of 0.14%.

Raymond James has upgraded its outlook for HealthEquity (HQY) from Outperform to Strong Buy. This upgrade was accompanied by a new price target of $115, which is slightly lower than the previous target of $120. The upgrade was based on the company's strong Q4 revenue performance, which exceeded estimates, despite concerns over fraud. The analyst, C. Gregory Peters, highlighted HealthEquity's long-term growth potential as a key factor in the upgrade.

This upgrade comes at a time when HealthEquity is facing scrutiny over fraud concerns. However, the company's strong revenue performance and long-term growth prospects have been noted by analysts, who believe that these factors outweigh the current challenges. The upgrade by Raymond James is expected to have a positive impact on the stock price, as it reflects the analyst's confidence in the company's future performance.